← feed

Is NCT02576548 results overdue?

Yes — results are overdue. Primary completion was 2018-05-23; the FDAAA-801 reporting deadline (2019-05-23) passed 2632 days ago and no results are posted on ClinicalTrials.gov.

A Phase 1/2 Study of MEDI4276 in Adults Subjects With Select HER2-expressing Advanced Solid Tumors.

NCT IDNCT02576548 ↗
SponsorMedImmune LLC (INDUSTRY)
PhasePHASE1
StatusCOMPLETED
Primary completion2018-05-23 (ACTUAL)
Reporting deadline2019-05-23 (completion + 365d)
Days overdue2632
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 6d7fb4d7e6da3203… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT02576548. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →